# Align Technology (ALGN) — Analyst Forecast

ALGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/algn/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 10 | 8 | 1 | 19 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $155.00 | $176.75 | $215.00 | 4 |

Last price $149.34 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 15, 2026 | Baird | Downgraded | Outperform → Neutral | $162.00 |
| Oct 14, 2026 | Leerink Partners | Maintained | Outperform | $215.00 |
| Oct 9, 2026 | Stifel | Maintained | Buy | $175.00 |
| Oct 5, 2026 | Evercore ISI Group | Downgraded | Outperform → In-Line | $155.00 |
| Jul 9, 2026 | BMO Capital | Initiated Coverage | Outperform | $209.00 |
| Apr 30, 2026 | Evercore ISI Group | Maintained | Outperform | $220.00 |
| Apr 24, 2026 | Morgan Stanley | Maintained | Equal-Weight | $188.00 |
| Apr 21, 2026 | Piper Sandler | Maintained | Overweight | $235.00 |
| Apr 15, 2026 | Citigroup | Initiated Coverage | Buy | $240.00 |
| Mar 17, 2026 | Barclays | Upgraded | Equal-Weight → Overweight | $200.00 |
| Feb 26, 2026 | Barclays | Maintained | Equal-Weight | $200.00 |
| Feb 9, 2026 | HSBC | Upgraded | Hold → Buy | $200.00 |
| Feb 5, 2026 | Morgan Stanley | Maintained | Equal-Weight | $169.00 |
| Feb 5, 2026 | Wells Fargo | Maintained | Overweight | $200.00 |
| Feb 5, 2026 | Evercore ISI Group | Maintained | Outperform | $200.00 |
| Feb 5, 2026 | UBS | Maintained | Neutral | $185.00 |
| Feb 5, 2026 | Piper Sandler | Maintained | Overweight | $220.00 |
| Feb 5, 2026 | Stifel | Maintained | Buy | $210.00 |
| Jan 20, 2026 | Mizuho | Maintained | Outperform | $200.00 |
| Dec 9, 2025 | Barclays | Initiated Coverage | Equal-Weight | $170.00 |

## Frequently Asked Questions

### What is the price target for ALGN stock?

The average 12-month analyst price target for Align Technology (ALGN) is $176.75, with a high estimate of $215.00 and a low of $155.00, across 4 analysts.

### Is ALGN a buy, sell, or hold?

Analysts covering Align Technology currently average a Buy rating: 10 buy, 8 hold and 1 sell, from 19 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for ALGN?

The average price target of $176.75 implies 18.35% upside from the last price of $149.34.

### What is the latest analyst rating on ALGN?

On Oct 15, 2026, Baird downgraded Align Technology to Neutral with a price target of $162.00.

## Similar Stocks

- [MCK](https://www.lighthorse.io/tickers/mck) — McKesson Corporation Common Stock
- [HAE](https://www.lighthorse.io/tickers/hae) — Haemonetics Corporation Common Stock
- [HSIC](https://www.lighthorse.io/tickers/hsic) — Henry Schein, Inc. - Common Stock
- [QTRX](https://www.lighthorse.io/tickers/qtrx) — Quanterix Corporation - Common Stock
- [CAH](https://www.lighthorse.io/tickers/cah) — Cardinal Health, Inc. Common Stock
- [HQY](https://www.lighthorse.io/tickers/hqy) — HealthEquity, Inc. - Common Stock
- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [RMD](https://www.lighthorse.io/tickers/rmd) — ResMed Inc. Common Stock
- [DXCM](https://www.lighthorse.io/tickers/dxcm) — DexCom, Inc. - Common Stock
- [NVST](https://www.lighthorse.io/tickers/nvst) — Envista Holdings Corporation Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).